| PF4V1 |
PF4V1, SCYB4V1: Platelet factor 4 variant precursor |
TRHR |
TRHR: Thyrotropin-releasing hormone receptor |
0.78 |
Evidence |
|
| PF4V1 |
PF4V1, SCYB4V1: Platelet factor 4 variant precursor |
F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
0.78 |
Evidence |
|
| IL8 |
IL8: Interleukin-8 precursor |
CCR5 |
CCR5: CCR5 receptor (Fragment) |
0.78 |
Evidence |
|
| IL8 |
IL8: Interleukin-8 precursor |
F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
0.78 |
Evidence |
|
| MMP7 |
MMP7, MPSL1, PUMP1: Matrilysin precursor |
CD44 |
IPI00305064 |
0.78 |
Evidence |
O
|
| IL3 |
IL3: Interleukin-3 precursor |
CSF2RB |
CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor |
0.78 |
Evidence |
O
|
| IL3 |
IL3: Interleukin-3 precursor |
IL12RB2 |
IL12RB2: Interleukin-12 receptor beta-2 chain precursor |
0.78 |
Evidence |
|
| IL3 |
IL3: Interleukin-3 precursor |
LIFR |
LIFR: Leukemia inhibitory factor receptor precursor |
0.78 |
Evidence |
|
| IL3 |
IL3: Interleukin-3 precursor |
GHR |
GHR: Growth hormone receptor precursor |
0.78 |
Evidence |
|
| MET |
MET: Hepatocyte growth factor receptor precursor |
TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
0.78 |
Evidence |
|
| MMP2 |
MMP2, CLG4A: 72 kDa type IV collagenase precursor |
CD44 |
IPI00305064 |
0.78 |
Evidence |
|
| CHRM2 |
CHRM2: Muscarinic acetylcholine receptor M2 |
CCL13 |
CCL13, MCP4, NCC1, SCYA13: Small-inducible cytokine A13 precursor |
0.78 |
Evidence |
|
| CHRM2 |
CHRM2: Muscarinic acetylcholine receptor M2 |
CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
0.78 |
Evidence |
|
| CHRM2 |
CHRM2: Muscarinic acetylcholine receptor M2 |
CCL1 |
CCL1, SCYA1: Small-inducible cytokine A1 precursor |
0.78 |
Evidence |
|
| RHO |
RHO, OPN2: Rhodopsin |
CCL14 |
CCL14, NCC2, SCYA14: Small-inducible cytokine A14 precursor |
0.78 |
Evidence |
|
| IGF1R |
IGF1R: Insulin-like growth factor 1 receptor precursor |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
0.78 |
Evidence |
|
| ADRB2 |
ADRB2, ADRB2R, B2AR: Beta-2 adrenergic receptor |
IL8 |
IL8: Interleukin-8 precursor |
0.78 |
Evidence |
|
| CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
0.78 |
Evidence |
|
| ICAM1 |
ICAM1: Intercellular adhesion molecule 1 precursor |
MSN |
MSN: Moesin |
0.78 |
Evidence |
O
|
| SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
HPN |
HPN, TMPRSS1: Serine protease hepsin |
0.78 |
Evidence |
|
| IL5 |
IL5: Interleukin-5 precursor |
IL9R |
IL9R: Interleukin-9 receptor precursor |
0.78 |
Evidence |
|
| IL5 |
IL5: Interleukin-5 precursor |
LIFR |
LIFR: Leukemia inhibitory factor receptor precursor |
0.78 |
Evidence |
|
| IL5 |
IL5: Interleukin-5 precursor |
MPL |
MPL, TPOR: Thrombopoietin receptor precursor |
0.78 |
Evidence |
|
| ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
0.78 |
Evidence |
|
| ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
0.78 |
Evidence |
|